Generative Data Intelligence

Tag: inhibitor

3 New League of Legends Custom Game Ideas

As thrilling as it is to play League of Legends, everyone needs a break sometimes. Whether it’s been a long work day or a...

Top News

BioAlberta Annual Achievement Awards

EDMONTON, Alberta–(BUSINESS WIRE)–BioAlberta announced the recipients of its 2023 Achievement Awards in recognition of the outstanding contributions of the individuals and companies whose innovation...

Sino Biopharmaceutical (1177.HK) Announces 2023 Interim Results

HONG KONG, Aug 25, 2023 - (ACN Newswire) - Sino Biopharmaceutical Limited ("Sino Biopharmaceutical" or the "Company", together with its subsidiaries, the "Group") (HKEX:1177), a leading innovation-driven pharmaceutical...

Laekna, a Biotechnology Company in China, Listed on the Main Board of the Hong Kong Stock Exchange

HONG KONG, June 29, 2023 - (ACN Newswire) - A biotechnology company in China - Laekna, Inc. (stock code: 2105.HK), today listed on the Main Board of The...

In a First, an AI-Designed Drug Is Being Tested in Humans to See if It Actually Works

Four years ago, biotech company Insilico Medicine used AI to design a molecule targeting a protein involved in fibrosis in just 46 days. It...

How 3D Changes in the Genome Turned Sharks Into Skates | Quanta Magazine

IntroductionThe marine creatures called skates skim along the sea bottom, rippling their winglike pectoral fins to propel themselves and to stir up small creatures...

Wild Rift patch 4.2 notes: Swain release, ADC revamp, and more

Wild Rift patch 4.2 is finally here — meaning Swain released as well. And with the release of the big patch, Wild Rift massively...

Sino Biopharm (1177.HK) Announces 2022 Annual Results

HONG KONG, Mar 31, 2023 - (ACN Newswire) - Sino Biopharmaceutical Limited ("Sino Biopharm" or the "Company", together with its subsidiaries, the "Group") (HKEX:1177), a leading innovation-driven pharmaceutical...

On-Demand Male Birth Control Immobilizes Sperm and Completely Wears Off in a Day

Late last year, a Virginia-based startup called Contraline started the initial clinical trial of its male birth control, a hydrogel that’s injected directly into...

The Cause of Depression Is Probably Not What You Think

IntroductionPeople often think they know what causes chronic depression. Surveys indicate that more than 80% of the public blames a “chemical imbalance” in the...

Inotrem Receives Funding From the Crohn’s & Colitis Foundation to Help Develop New Therapeutic Approaches in Inflammatory Bowel Disease (IBD)

The funding will support the development of INO-02 a new long-acting therapeutic approach to modulate the TREM-1 pathway. PARIS–(BUSINESS WIRE)–#IBD—Inotrem, an advanced clinical stage biotech...

Gilead to Acquire All Remaining Rights to Potential First-in-Class Immunotherapy GS-1811 From Jounce Therapeutics

— Agreement Covers Buyout of Remaining Financial Obligations for Anti-CCR8 Antibody in Development as a Potential Treatment for Solid Tumors — FOSTER CITY, Calif. &...

CMS (867.HK) Joins Hand with Incyte on Ruxolitinib Cream, Brings 1st Repigmentation Drug for Vitiligo Patient

SHENZHEN, CHINA, Dec 6, 2022 - (ACN Newswire) - China Medical System Holdings Limited (CMS, 867.HK) acquired another blockbuster innovative product in dermatology filed....

Latest Intelligence

spot_img
spot_img
spot_img

Chat with us

Hi there! How can I help you?